Impact of Yoga Therapy for the Management of Type-2 Diabetes: A Systematic Review

Abstract

Background: The most prevalent type of diabetes, type 2 diabetes mellitus (T2DM), accounts for more than 90% of cases of diabetes globally. As of right now, 425 million adults worldwide are believed to have type-2 diabetes; by 2045, that number is expected to increase to 629 million. The main cause of T2DM is the deterioration of the regular functioning of pancreatic (β-cells) and insulin resistance. Yogic therapy is a proven method of stabilizing an individual from a metabolic disorder, and lifestyle disorder. Through asanas and pranayama, we can control the blood sugar level. Objective: To assess Yoga Therapy's effectiveness for managing Madhumeha (Diabetes mellitus-II) in the review article. Design: The PubMed, Google Scholar, Embase, and Cochrane databases were searched from January 2022 to February 2023 for eligible RCTs using the keywords ‘Yoga Therapy’ and ‘Type-II Diabetes Mellitus’. Intervention: Treatment with any regimen of Yoga Therapy or Yogic Intervention (Asana, Pranayama). Outcome Measures: The number and results of the studies were identified and presented as a systematic review. Result: This systematic review resulted in understanding the different mechanisms by which Yoga Therapy works in type-2 Diabetes Mellitus.  Which include Asanas and Pranayama, were effective in regulating fasting blood sugar (p < 0.05), Postprandial Fasting blood Sugar level (p < 0.0001), HbA1c (p < 0.001), Triglyceride ((p<0.05), Low-Density Lipoprotein (p>0.05) and High-Density Lipoprotein (p<0.05), BMI Body Mass Index (p < 0.001), BP Blood Pressure (P= 0.072), Serum (p-value <0.0001) relative to the control group.